Cells respond to many hormones, neurotransmitters, bioactive peptides and sensory molecules through G protein signalling. The process begins with the binding of the signalling molecule to the extracellular face of a G‐protein‐coupled receptor (GPCR) that initiates binding of the G protein heterotrimer on the intracellular side of the receptor. This interaction causes exchange of GDP for GTP on the G protein α subunit, triggering a conformational change that dissociates the Gα‐GTP from Gβγ. These G protein subcomplexes then interact with effector enzymes and ion channels and elicit a cellular response to the signal. GPCRs constitute the largest class of transmembrane receptors, with 800 genes in the human genome. Consequently, G protein signalling contributes to almost all aspects of human physiology, and GPCRs are the single most common class of drug targets.
Key Concepts
G protein signalling contributes to almost all aspects of human physiology, including sensory perception, neuronal transmission and hormone secretion.
Agonist binding to a G‐protein‐coupled receptor initiates an interaction with the G protein heterotrimer that triggers nucleotide exchange on the G protein α subunit (Gα).
The binding of GTP to Gα causes its dissociation from the receptor and the G protein βγ dimer (Gβγ), allowing Gα‐GTP and Gβγ to interact with effector enzymes and ion channels.
Effector enzymes and ion channels change the concentration of second messenger molecules or the membrane potential to elicit the cellular response to the agonist.
The rate of GTP hydrolysis by Gα, which determines the duration of the G protein signal, is controlled by GTPase‐accelerating proteins called regulators of G protein signalling.
To function, the G protein heterotrimer must be assembled from its individual subunits by molecular chaperones.